China Biologic Products Holdings (CBPO) EBITDA US GAAP (year values)

FY2016 FY2017 FY2018 FY2019 FY2020   LTM ? CAGR 5 years ?
EBITDA, bln rub ? 142.9 145.6 169.7 218.3 241.6   241.6  
Changes by years, y/y, % +18% +2% +17% +29% +11%     +14.9%

China Biologic Products Holdings. EBITDA US GAAP, bln rub

China Biologic Products Holdings. EBITDA US GAAP, changes, %

China Biologic Products Holdings. EBITDA US GAAP, sum by quarters, bln rub

China Biologic Products Holdings (CBPO) EBITDA US GAAP (quarter values)

FY2019Q4 FY2020Q1 FY2020Q2 FY2020Q3 FY2020Q4   LTM ?
EBITDA, bln rub ? 28.5 80.6 53.8 63.0 44.2   241.6
Changes by years, y/y, % -41% +37% -15% -7% +55%    
Changes by quarters, q/q, % -58% +183% -33% +17% -30%    

China Biologic Products Holdings. EBITDA US GAAP, bln rub

China Biologic Products Holdings. EBITDA US GAAP, changes, y/y, %

China Biologic Products Holdings. EBITDA US GAAP, changes, q/q, %